Introduction {#Sec1}
============

The genus *Aesculus*, which belongs to the family *Hippocastanaceae* contains about 30 species found worldwide. The dried seeds of *Aesculus chinensis* Bge. var. *chekiangensis* (Hu et Fang) Fang, *Aesculus chinensis* Bge and *Aesculus wilsonii* Rehd are commonly used to treat chest and abdomen pain, dysentery and ague \[[@CR1], [@CR2]\] in traditional Chinese medicine. Previous studies on the genus of *Aesculus* revealed the presences of diverse secondary metabolites such as triterpenoids \[[@CR3]--[@CR7]\], flavonoids \[[@CR8], [@CR9]\], coumarins \[[@CR10]\] and steroids \[[@CR11]\]. And a number of pharmacological studies have suggested that *A. chinensis* exhibited beneficial effects on antitumor \[[@CR12]\], neuroprotective \[[@CR13]\], anti-inflammatory \[[@CR14]\] and cardio-protective activities \[[@CR15]\]. Nevertheless, compared to other species of *Aesculus* genus, the chemical investigation of *Aesculus chinensis* Bge. var. *chekiangensis* (Hu et Fang) Fang is limited. Our interests in cytotoxic and neuroprotective components from *A. chinensis* Bge. var. *chekiangensis* (Hu et Fang) Fang have led to the isolation of numerous new ones \[[@CR16], [@CR17]\]. As a continuous search for structurally novel compounds with diverse bioactivities, three new phenylethanol glycosides (**1**-**3**) and one known analog (**4**) were obtained (Fig. [1](#Fig1){ref-type="fig"}), which represent the first examples of phenylethanol glycosides obtained from the genus of *Aesculus*. Herein, the isolation, structure identification and biological evaluation of **1-4** are described.Fig. 1The structures of isolated compounds

Methods {#Sec2}
=======

General experimental procedures {#Sec3}
-------------------------------

The chemicals and material were similar to our previous researches \[[@CR16], [@CR17]\].

Plant material {#Sec4}
--------------

The plant was the same batch of medicinal material as our previous reports \[[@CR16], [@CR17]\].

Extraction and isolation {#Sec5}
------------------------

The extracted method was the same to our previous studies \[[@CR16], [@CR17]\]. Chopped, dried seeds of *A. chinensis* Bge. (8.8 kg) were extracted with 70% ethanol, then partitioned via D101 resin column eluting with a stepwise gradient of H~2~O-EtOH.

The 60% EtOH-H~2~O part was loaded onto a silica gel column using CH~2~Cl~2~/CH~3~OH (100:1 → 1:1) to yield 4 fractions (A--D). Fraction A was further separated by RP C~18~ CC (MeOH--H~2~O, from 0:100 to 100:0) to give four subfractions (A1--A4). Subfraction A2 was chromatographed over a Sephadex LH-20 column (MeOH) then RP-HPLC (MeOH--H~2~O, 35:65, 3.0 mL/min) to give compounds **1** (11.0 mg) and **4** (20.0 mg). Subfraction A3 was further subdivided with an ODS RP-C18 column (MeOH/H~2~O, 10:90 to 100: 0) to give seven subfractions (A3A--A3G). The subfraction A3G was applied to a Sephadex LH-20 column (MeOH), and then purified by recycling preparative HPLC with 40% MeOH/H~2~O to yield compounds **2** (3.7 mg) and **3** (9.0 mg).

### 4-methoxy-phenylethanol-8-*O*-*α*-[l]{.smallcaps}-rhamnopyranosyl-(1 → 6)-*β*-[d]{.smallcaps}-glucopyranoside (1) {#Sec6}

Brown amorphous powder; \[*α*\]25 *D*--7.3 (*c* 0.10, MeOH); Proton nuclear magnetic resonance (^1^H-NMR) and carbon-13 nuclear magnetic resonance (^13^C-NMR): Table [1](#Tab1){ref-type="table"}; HR-ESI--MS: *m/z* 505.1918 \[M + COOH\]^−^ (calculated for C~22~H~33~O~13~, 505.1921).Table 1^1^H (600 MHz) and ^13^C (150 MHz) NMR data of **1**--**3** (*δ* in ppm, in DMSO-*d*~6~)Position123*δ*~C~*δ*~H~*δ*~C~*δ*~H~*δ*~C~*δ*~H~1130.5130.7130.62129.97.17 (1H, d, *J *= 8.5 Hz)130.07.17 (1H, d, *J* = 8.7 Hz)130.07.18 (1H, d, *J *= 8.7 Hz)3113.76.83 (1H, d, *J *= 8.5 Hz)113.66.83 (1H, d, *J* = 8.7 Hz)113.66.82 (1H, d, *J* = 8.7 Hz)4157.6157.6157.75113.76.83 (1H, d, *J *= 8.5 Hz)113.66.83 (1H, d, *J* = 8.7 Hz)113.66.82 (1H, d, *J* = 8.7 Hz)6129.97.17 (1H, d, *J *= 8.5 Hz)130.07.17 (1H, d, *J* = 8.7 Hz)130.07.18 (1H, d, *J *= 8.7 Hz)734.82.78 (2H, dt, *J *= 8.2, 6.3 Hz)34.72.78 (2H, dt, *J *= 8.2, 6.4 Hz)34.62.78 (2H, dt, *J *= 8.4, 6.6 Hz)869.93.83 (1H, dt, *J *= 8.2, 6.3 Hz) 3.62 (1H, overlap)69.83.89 (1H, dt, *J *= 8.2, 6.4 Hz) 3.60 (1H, overlap)69.93.92 (1H, dt, *J *= 8.4, 6.6 Hz) 3.60 (1H, overlap)4-OCH~3~55.03.71 (3H, s)55.03.71 (3H, s)54.93.71 (3H, s)1′103.04.17 (1H, d, *J *= 7.7 Hz)101.34.33 (1H, d, *J *= 7.7 Hz)101.64.39 (1H, d, *J *= 7.5 Hz)2′73.42.94 (1H, t, *J *= 8.5 Hz)82.23.23 (1H, dd, *J *= 9.1, 7.7 Hz)79.63.44 (1H, m)3′76.73.13 (1H, t, *J *= 8.9 Hz)76.73.10 (1H, m)86.23.49 (1H, t, *J *= 8.8 Hz)4′70.22.99 (1H, t, *J *= 9.1 Hz)69.83.10 (1H, m)68.43.19 (1H, m)5′75.43.26 (1H, m)76.13.36 (1H, m)76.13.18 (1H, m)6′67.03.81 (1H, dd, *J *= 11.2, 2.0 Hz) 3.42 (1H, dd, *J *= 11.2, 6.0 Hz)60.93.65 (1H, m) 3.42 (1H, dd, *J *= 11.2, 5.2 Hz)61.23.65 (1H, m) 3.47 (1H, m)1′′100.84.59 (1H, d, *J *= 1.2 Hz)104.14.41 (1H, d, *J *= 7.8 Hz)102.84.55 (1H, d, *J *= 8.0 Hz)2′'70.53.60 (1H, m)74.93.00 (1H, dd, *J *= 8.4, 7.8 Hz)74.52.94 (1H, dd, *J *= 8.5, 5.9 Hz)3′′70.73.42 (1H, m)77.13.08 (1H, m)76.43.19 (1H, m)4′′72.03.17 (1H, t, *J *= 9.1 Hz)69.93.10 (1H, m)70.03.62 (1H, m)5′'68.43.45 (1H, m)76.13.16 (1H, m)76.23.16 (1H, m)6′′18.01.12 (3H, d, *J *= 6.2 Hz)61.03.65 (1H, m) 3.49 (1H, dd, *J *= 11.2, 5.5 Hz)61.03.67 (1H, m) 3.39 (1H, dd, *J *= 11.8, 5.9 Hz)1′′′103.44.38 (1H, d, *J *= 7.9 Hz)2′′′73.73.04 (1H, d, *J *= 8.7 Hz)3′′′76.93.07 (1H, m)4′′′70.13.06 (1H, m)5′′′76.83.05 (1H, m)6′′′60.73.69 (1H, m) 3.45 (1H, m)

### 4-methoxy-phenylethanol-8-*O*-*β*-[d]{.smallcaps}-glucopyranosyl-(1 → 2)-*β*-[d]{.smallcaps}-glucopyranoside (2) {#Sec7}

Brown amorphous powder; \[*α*\]25 *D*--11.2 (*c* 0.11, MeOH); ^1^H-NMR and ^13^C-NMR: Table [1](#Tab1){ref-type="table"}; HR-ESI--MS: *m/z* 521.1870 \[M + COOH\]^−^ (calculated for C~22~H~33~O~14~, 521.1870).

### 4-methoxy-phenylethanol-8-*O*-*β*-[d]{.smallcaps}-glucopyranosyl-(1 → 2)-\[*β*-[d]{.smallcaps}-glucopyranosyl-(1 → 3)\]-*β*-[d]{.smallcaps}-glucopyranoside (3) {#Sec8}

Brown amorphous powder; \[*α*\]25 *D*--14.6 (*c* 0.10, MeOH); ^1^H-NMR and ^13^C-NMR: Table [1](#Tab1){ref-type="table"}; HR-ESI--MS: *m/z* 683.2398 \[M + COOH\]^−^ (calculated for C~28~H~43~O~19~, 683.2399).

Hydrolysis and determination of absolute configuration of sugars {#Sec9}
----------------------------------------------------------------

Compounds **1**--**3** (1.0 mg, respectively) was hydrolyzed with 2 M HCl (4.0 mL) at 90 °C for 2 h. Then the hydrolysed materials were disposed and tested by means of the procedure described in our previous work \[[@CR16], [@CR17]\].

Neuroprotective effect assay {#Sec10}
----------------------------

Compounds **1**-**4** were assayed for their neuroprotective effects against CoCl~2~-induced PC12 cell injury \[[@CR18]\] by 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT) method with trolox as the positive control according to our previously reported procedure \[[@CR16], [@CR17]\]. PC12 cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum as well as 100 U/mL penicillin/streptomycin and were incubated at 37 °C with 5% CO~2~. PC12 cells were placed into a 96-well plate at a density of 2 × 10^4^ cells/well and kept there for 24 h. Cells were incubated with test compounds and trolox (10 μM) for 2 h. To induce an oxidative stress, 1 mM CoCl~2~ was added to the cells and incubated for 24 h. Then, the supernatant was changed with 100 μL MTT solution (5 mg/mL) for 2.5 h, the plate was vibrated, and the absorbance at 490 nm was measured using a microplate reader.

Cytotoxicity assay {#Sec11}
------------------

Cell viability was determined with the MTT method \[[@CR19], [@CR20]\]. The human hepatocellular carcinomas cells (HepG2), the human colorectal carcinoma cells (HCT-116) and the human gastric carcinoma cells (MGC-803) were purchased from ATCC. HepG2, MGC-803 and HCT-116 were respectively cultured in DMEM and RPMI-1640 mediums, which were supplemented with 10% fetal bovine serum at 37 °C in a humidified atmosphere containing 5% CO~2~. HepG2, HCT-116, and MGC-803 cells (1 × 10^4^) were seeded in 96-well tissue culture plates. Cells were treated in triplicate with five concentrations (50, 25, 12.5, 6.25 and 3.125 μM) of the tested compounds for 24 h, with 5-fluorouracil (5-FU) as positive control. Subsequently, 100 μL of MTT (5 mg/mL) was added and the cells were incubated for additional 2.5 h. Thereafter, the supernatant was discarded and 0.15 ml of DMSO was added to each well, then the plate was mixed on a microshaker for 10 min and read on a microplate reader at 490 nm.

Results and discussion {#Sec12}
======================

Compound **1** was obtained as brown amorphous powder with a molecular formula of C~21~H~32~O~11~ deduced from its HR-ESI-MS spectrum (*m/z* 505.1918 \[M + COOH\]^−^, calcd. for C~22~H~33~O~13~, 505.1921). The ^1^H-NMR spectrum of compound **1** exhibited signals characteristic for a 1, 4-disubstituted benzene ring \[*δ*~H~ 7.17 (2H, d, *J* = 8.5 Hz, H-2, 6), 6.83 (2H, d, *J* = 8.5 Hz, H-3, 5)\], an ethoxy moiety \[*δ*~H~ 2.78 (2H, dt, *J *= 8.2, 6.3 Hz), 3.83 (1H, dt, *J *= 8.2, 6.3 Hz)\] as well as a *O*-methyl at *δ*~H~ 3.71 (3H, s) (Table [1](#Tab1){ref-type="table"}). The heteronuclear multiple bond correlations (HMBC) (Fig. [2](#Fig2){ref-type="fig"}) of H-2 (*δ*~H~ 7.17) to C-4 (*δ*~C~ 157.6), C-6 (*δ*~C~ 129.9), C-7 (*δ*~C~ 34.8); H-3 (*δ*~H~ 6.83) to C-1 (*δ*~C~ 130.5), C-5 (*δ*~C~ 113.7); H-8 (*δ*~H~ 3.83) to C-1 (*δ*~C~ 130.5) and OCH~3~ (*δ*~H~ 3.71) to C-4 (*δ*~C~ 157.6) indicated **1** contains a 4-methoxy-phenylethanol moiety.Fig. 2Selected HMBC (H → C) correlations of compounds **1-3**

The two anomeric protons at *δ* 4.17 (1H, d, *J *= 7.7 Hz), 4.59 (1H, d, *J *= 1.2 Hz) correlated with carbons at *δ* 103.0 and 100.8 in heteronuclear single quantum coherence (HSQC) spectrum, respectively, indicated a disaccharide residue. Acid hydrolysis of **1** liberated [d]{.smallcaps}-glucose and [l]{.smallcaps}-rhamnose, which were identified by HPLC analysis after derivatization \[[@CR21], [@CR22]\]. The *β*-orientation of the glucopyranosyl unit was deduced from the coupling constant (*J* = 7.7 Hz, H-1′). The *α*- anomeric configuration of rhamnose was determined from the absence of nuclear overhauser effect spectroscopy (NOESY) correlations between protons H‑1 and H‑3/H‑5. The *β*-[d]{.smallcaps}-glucose was attached to the 4-methoxy-phenylethanol nucleus at C-8, evidenced by the HMBC correlation between H-1′ (*δ*~H~ 4.17) to C-8 (*δ*~C~ 69.9). In addition, the downfield chemical shift of C-6′ (*δ*~C~ 67.0) of the glucose coupled with the cross peak of H-1′′ (*δ*~H~ 4.59) to C-6′ (*δ*~C~ 67.0) in HMBC spectrum suggesting the *α*-[l]{.smallcaps}-rhamnose was linked to C-6′. Based on these data, compound **1** was concluded to be 4-methoxy-phenylethanol‐8-*O*-*α*-[l]{.smallcaps}-rhamnopyranosyl-(1 → 6)-*β*-[d]{.smallcaps}-glucopyranoside.

The elemental formula of compound **2** was confirmed to be C~21~H~32~O~12~ with one oxygen more than that of **1** according to the \[M + COOH\]^−^ ion peak at *m/z* 521.1870 in its HRESIMS spectrum. The ^1^H and ^13^C NMR data of **2** revealed a close resemblance to **1** except for the corresponding signals to the two sugar units. Careful analysis of the NMR data and the acid hydrolysis results affirmed the existence of two *β*-[d]{.smallcaps}-glucose groups in **2** instead of one *β*-[d]{.smallcaps}-glucose and one *α*-[l]{.smallcaps}-rhamnose in **1**. HMBC correlations from H-1′ (*δ*~H~ 4.33) to C-8 (*δ*~C~ 69.8) and H-1′′ (*δ*~H~ 4.41) to C-2′ (*δ*~C~ 82.8) revealed the position and sequences of the sugar moiety in **2** as shown in Fig. [2](#Fig2){ref-type="fig"}. Hence, compound **2** was assigned as 4-methoxy-phenylethanol-8-*O*-*β*-[d]{.smallcaps}-glucopyranosyl-(1 → 2)-*β*-[d]{.smallcaps}-glucopyranoside.

Compound **3** was also acquired as a brown solid with the molecular formula of C~27~H~42~O~17~ (*m/z* 683.2398 \[M + COOH\]^−^; calcd. for C~28~H~43~O~19~, 683.2399), which is 162 mass units more than that of **2**. The NMR data of **3** were closely resemble to those of **2**, indicating the same aglycone with the difference of an additional hexose moiety. [d]{.smallcaps}-glucose was afforded from **3** via the same procedure as before and the *β* configuration was inferred from the large coupling constants: \[*δ*~H~ 4.39 (1H, d, *J* = 7.5 Hz, H-1′), 4.55 (1H, d, *J* = 8.0 Hz, H-1′′), 4.38 (1H, d, *J* = 7.9 Hz, H-1′′′)\]. HMBC correlations from H-1′ (*δ*~H~ 4.39) to C-8 (*δ*~C~ 69.9) supported the attachment of the sugar units to C-8. The sequence of the sugar chain was further established by the long correlations of H-1′′ (*δ*~H~ 4.55) and C-2′ (*δ*~C~ 79.6), H-1′′′ (*δ*~H~ 4.38) and C-3′ (*δ*~C~ 86.2) (Fig. [2](#Fig2){ref-type="fig"}). Consequently, compound **3** was assigned as 4-methoxy-phenylethanol-8-*O*-*β*-[d]{.smallcaps}-glucopyranosyl-(1 → 2)-\[*β*-[d]{.smallcaps}-glucopyranosyl-(1 → 3)\]-*β*-[d]{.smallcaps}-glucopyranoside.

The other known one, phenylethanol-8-*O*-*α*-[l]{.smallcaps}-rhamnopyranosyl-(1 → 6)-*β*-[d]{.smallcaps}-glucopyranoside (**4**) were also obtained and identified by NMR analysis and comparison with literature data \[[@CR23]\].

All compounds (**1**--**4**) were tested in three human cancer cell lines, HepG2, HCT-116 and MGC-803, using 5-FU as the positive control. However, they did not show obvious cytotoxicity (IC~50~ \> 50 μM).

The neuroprotective effects of **1**--**4** were also evaluated in CoCl~2~-induced PC12 cell damage \[[@CR24]\] by MTT assay. According to the references \[[@CR25], [@CR26]\] and our study, the positive control, trolox, exhibited statistically significant neuroprotective effect at 10 μM (Fig. [3](#Fig3){ref-type="fig"}). Therefore, the concentration of 10 μM was selected for the cytotoxic and neuroprotective evaluation of these compounds. First, the cytotoxic activity of compounds **1**--**4** against PC12 cell line was tested and none of them showed cytotoxicity at 10 μM (Additional file [1](#MOESM1){ref-type="media"}: Fig. S16). Subsequently, 10 µM compounds were bioassayed for their neuroprotective properties. And according to Fig. [3](#Fig3){ref-type="fig"}, compound **3** exhibited moderate activities against CoCl~2~-induced PC12 cell injury.Fig. 3Neuroprotective activities of compounds **1-4** (10 μM) against CoCl~2~-induced cell death in PC12 cells. The data (cell viability, measured by MTT assay) are expressed as mean ± SD. Three independent experiments were performed. Trolox was used as the positive control at 10 μM. Compared with CoCl~2~ treated group, \**P* \< 0.05, \*\**P* \< 0.01

Conclusion {#Sec13}
==========

In this paper, three new phenylethanol glycosides (**1-3**) and one known compound (**4**) were obtained from the seeds of *A. chinensis* Bge. var. *chekiangensis*., which represents the first isolation of phenylethanol glycosides from the genus of *Aesculus*. The findings also provided more insights into the chemotaxonomy of the *Aesculus* genus. Besides, the neuroprotective activities of the phenylethanol glycosides were also evaluated and compound **3** exhibited statistically significant neuroprotective activity.

Supplementary information
=========================

 {#Sec14}

**Additional file 1:** HR-ESI-MS, 1D- and 2D-NMR spectra of compounds **1**--**3** (**Figures S1**--**S15**), cytotoxic activities of compounds **1**--**4** on PC12 cells at 10 µM (**Figure S16**).

DMSO-*d*~6~

:   Deuterated dimethyl sulfoxide

^1^H-NMR

:   Proton nuclear magnetic resonance

^13^C-NMR

:   Carbon-13 nuclear magnetic resonance
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:   Heteronuclear multiple bond correlation
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:   Heteronuclear single quantum coherence

NOESY

:   Nuclear overhauser effect spectroscopy
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:   The human hepatocellular carcinomas cells
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:   The human colorectal carcinoma cells
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:   The human gastric carcinoma cells

MTT

:   3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide
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